Bacterial endotoxin detection is a critical step in ensuring the safety of pharmaceutical and medical products. Traditional methods, though considered the gold standard, are labor-intensive, time-consuming, heavily dependent on operator expertise, and susceptible to environmental and human errors. To address these challenges, BIOENDO has developed the Phoenix Q Series Intelligent Automatic Endotoxin Detection Robot System, which integrates automated robotics with endotoxin testing. The system enables fully automated experimental workflows without human intervention, minimizing manual errors, enhancing reproducibility, and reducing overall detection costs. It is compatible with a wide range of detection methods, including kinetic turbidimetric assay, kinetic chromogenic assay, micro-kinetic chromogenic assay, recombinant cascade chromogenic assay, and the monocyte activation test (MAT). Featuring a user-friendly software interface, one-click experiment setup, and automated data recording and reporting, the Phoenix Q Series significantly improves detection efficiency and frees operators from complex manual procedures.